Pro-Dex (PDEX) Competitors $47.71 +2.66 (+5.90%) As of 07/3/2025 03:49 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock PDEX vs. AVNS, EMBC, BVS, KIDS, RXST, BFLY, AXGN, DCTH, SMLR, and TMCIShould you be buying Pro-Dex stock or one of its competitors? The main competitors of Pro-Dex include Avanos Medical (AVNS), Embecta (EMBC), Bioventus (BVS), OrthoPediatrics (KIDS), RxSight (RXST), Butterfly Network (BFLY), AxoGen (AXGN), Delcath Systems (DCTH), Semler Scientific (SMLR), and Treace Medical Concepts (TMCI). These companies are all part of the "medical equipment" industry. Pro-Dex vs. Its Competitors Avanos Medical Embecta Bioventus OrthoPediatrics RxSight Butterfly Network AxoGen Delcath Systems Semler Scientific Treace Medical Concepts Pro-Dex (NASDAQ:PDEX) and AVANOS MEDICAL (NYSE:AVNS) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, earnings, profitability, risk, institutional ownership, media sentiment, analyst recommendations and dividends. Do analysts recommend PDEX or AVNS? Pro-Dex currently has a consensus price target of $56.00, suggesting a potential upside of 17.38%. Given Pro-Dex's stronger consensus rating and higher probable upside, analysts clearly believe Pro-Dex is more favorable than AVANOS MEDICAL.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Pro-Dex 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00AVANOS MEDICAL 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has higher valuation & earnings, PDEX or AVNS? Pro-Dex has higher earnings, but lower revenue than AVANOS MEDICAL. AVANOS MEDICAL is trading at a lower price-to-earnings ratio than Pro-Dex, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPro-Dex$64.12M2.43$2.13M$2.8017.04AVANOS MEDICAL$687.80M0.83-$392.10M-$8.37-1.48 Do insiders & institutionals hold more shares of PDEX or AVNS? 15.3% of Pro-Dex shares are owned by institutional investors. Comparatively, 95.2% of AVANOS MEDICAL shares are owned by institutional investors. 47.5% of Pro-Dex shares are owned by company insiders. Comparatively, 2.6% of AVANOS MEDICAL shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Is PDEX or AVNS more profitable? Pro-Dex has a net margin of 14.61% compared to AVANOS MEDICAL's net margin of -55.80%. Pro-Dex's return on equity of 29.08% beat AVANOS MEDICAL's return on equity.Company Net Margins Return on Equity Return on Assets Pro-Dex14.61% 29.08% 16.19% AVANOS MEDICAL -55.80%6.26%4.63% Which has more volatility & risk, PDEX or AVNS? Pro-Dex has a beta of 0.19, suggesting that its stock price is 81% less volatile than the S&P 500. Comparatively, AVANOS MEDICAL has a beta of 1.12, suggesting that its stock price is 12% more volatile than the S&P 500. Does the media refer more to PDEX or AVNS? In the previous week, Pro-Dex's average media sentiment score of 1.00 beat AVANOS MEDICAL's score of 0.00 indicating that Pro-Dex is being referred to more favorably in the media. Company Overall Sentiment Pro-Dex Positive AVANOS MEDICAL Neutral SummaryPro-Dex beats AVANOS MEDICAL on 12 of the 15 factors compared between the two stocks. Get Pro-Dex News Delivered to You Automatically Sign up to receive the latest news and ratings for PDEX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding PDEX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PDEX vs. The Competition Export to ExcelMetricPro-DexMED/DENTAL IndustryMedical SectorNASDAQ ExchangeMarket Cap$155.94M$15.70B$5.56B$9.05BDividend YieldN/A1.40%5.24%4.01%P/E Ratio17.0419.9027.6120.24Price / Sales2.432.21416.87118.48Price / Cash49.9417.3536.8958.10Price / Book5.283.838.035.67Net Income$2.13M$430.42M$3.18B$249.21M7 Day Performance6.31%1.64%2.93%3.28%1 Month Performance12.98%4.02%3.75%5.55%1 Year Performance173.41%21.79%35.20%21.09% Pro-Dex Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PDEXPro-Dex2.4766 of 5 stars$47.71+5.9%$56.00+17.4%+178.5%$155.94M$64.12M17.04140Positive NewsAVNSAvanos MedicalN/A$12.25+0.3%N/A-36.4%$564.64M$689.20M-1.462,227EMBCEmbecta4.1447 of 5 stars$9.69+0.5%$19.33+99.5%-14.5%$563.39M$1.12B10.772,100BVSBioventus2.7088 of 5 stars$6.62-2.2%$14.33+116.5%+21.3%$543.79M$567.70M-10.851,200Positive NewsKIDSOrthoPediatrics3.913 of 5 stars$21.48+0.5%$35.83+66.8%-25.0%$519M$204.73M-12.27200RXSTRxSight1.7594 of 5 stars$13.00+2.6%$37.90+191.5%-76.8%$514.87M$139.93M-19.40220News CoveragePositive NewsBFLYButterfly Network2.4647 of 5 stars$2.00+1.8%$4.00+100.5%+100.8%$484.69M$82.06M-6.88460News CoverageAnalyst ForecastGap UpAXGNAxoGen2.0257 of 5 stars$10.85+3.3%$22.20+104.6%+42.6%$478.21M$187.34M-72.33450Positive NewsHigh Trading VolumeDCTHDelcath Systems3.5184 of 5 stars$13.60+0.2%$24.00+76.5%+60.9%$472.59M$37.21M-27.2060Analyst DowngradeSMLRSemler Scientific1.826 of 5 stars$38.74+0.6%$71.00+83.3%+21.7%$429.34M$56.29M-14.84120TMCITreace Medical Concepts2.6391 of 5 stars$5.88+2.3%$10.16+72.7%-8.5%$361.62M$209.36M-6.92250Positive News Related Companies and Tools Related Companies AVNS Competitors EMBC Competitors BVS Competitors KIDS Competitors RXST Competitors BFLY Competitors AXGN Competitors DCTH Competitors SMLR Competitors TMCI Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PDEX) was last updated on 7/5/2025 by MarketBeat.com Staff From Our PartnersA new rule goes live in July — and the banks are quietly cashing inA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredThe #1 AI Energy StockNearly $600 billion is projected to be spent on AI data centers this year. That's because the ones being bu...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pro-Dex, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pro-Dex With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
